JP2017537130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537130A5 JP2017537130A5 JP2017531184A JP2017531184A JP2017537130A5 JP 2017537130 A5 JP2017537130 A5 JP 2017537130A5 JP 2017531184 A JP2017531184 A JP 2017531184A JP 2017531184 A JP2017531184 A JP 2017531184A JP 2017537130 A5 JP2017537130 A5 JP 2017537130A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- hydrogel
- particles
- functional group
- xerogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 claims description 44
- 239000003814 drug Substances 0.000 claims description 36
- 229940124597 therapeutic agent Drugs 0.000 claims description 32
- 239000000017 hydrogel Substances 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 22
- 239000002243 precursor Substances 0.000 claims description 19
- 125000000524 functional group Chemical group 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 9
- 238000013268 sustained release Methods 0.000 claims description 8
- 239000012730 sustained-release form Substances 0.000 claims description 8
- 238000006065 biodegradation reaction Methods 0.000 claims description 5
- 230000003111 delayed effect Effects 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 230000000269 nucleophilic effect Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 12
- 230000001934 delay Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462089994P | 2014-12-10 | 2014-12-10 | |
| US62/089,994 | 2014-12-10 | ||
| PCT/US2015/064975 WO2016094646A1 (en) | 2014-12-10 | 2015-12-10 | Hydrogel drug delivery implants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020201207A Division JP2021046429A (ja) | 2014-12-10 | 2020-12-03 | ハイドロゲル薬物送達インプラント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537130A JP2017537130A (ja) | 2017-12-14 |
| JP2017537130A5 true JP2017537130A5 (https=) | 2019-01-24 |
| JP7092502B2 JP7092502B2 (ja) | 2022-06-28 |
Family
ID=55070156
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017531184A Active JP7092502B2 (ja) | 2014-12-10 | 2015-12-10 | ハイドロゲル薬物送達インプラント |
| JP2020201207A Pending JP2021046429A (ja) | 2014-12-10 | 2020-12-03 | ハイドロゲル薬物送達インプラント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020201207A Pending JP2021046429A (ja) | 2014-12-10 | 2020-12-03 | ハイドロゲル薬物送達インプラント |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160166504A1 (https=) |
| EP (2) | EP3229779B1 (https=) |
| JP (2) | JP7092502B2 (https=) |
| KR (1) | KR20170117384A (https=) |
| CN (2) | CN120501693A (https=) |
| AU (1) | AU2015360469B2 (https=) |
| CA (1) | CA2969716C (https=) |
| WO (1) | WO2016094646A1 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2939952C (en) | 2013-03-05 | 2022-03-22 | Morgan V. Fedorchak | Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery |
| US20220118416A1 (en) * | 2020-10-18 | 2022-04-21 | Pathak Holdings Llc | Crosslinked multilayered material compositions, methods for their preparation and applications thereof |
| CN107278151A (zh) | 2014-12-15 | 2017-10-20 | 约翰霍普金斯大学 | 舒尼替尼制剂及其在治疗青光眼中的使用方法 |
| US9855317B2 (en) | 2015-04-27 | 2018-01-02 | Reflex Medical, Inc. | Systems and methods for sympathetic cardiopulmonary neuromodulation |
| EP4279064A3 (en) * | 2015-05-12 | 2024-02-28 | Incept, LLC | Drug delivery from hydrogels |
| US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
| CN108367079B (zh) | 2015-11-12 | 2022-11-22 | 灰色视觉公司 | 用于治疗的聚集性微粒 |
| KR20180086468A (ko) | 2015-11-25 | 2018-07-31 | 인셉트, 엘엘씨 | 형상 변형 약물 전달 장치 및 방법 |
| US11246879B2 (en) | 2016-02-09 | 2022-02-15 | Tulai Therapeutics, Inc. | Methods, agents, and devices for local neuromodulation of autonomic nerves |
| WO2017165449A1 (en) * | 2016-03-22 | 2017-09-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular biologic delivery |
| US11154547B2 (en) | 2016-06-29 | 2021-10-26 | Tulavi Therapeutics, Inc. | Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system |
| EP3487586A4 (en) * | 2016-07-20 | 2020-03-04 | Emory University | FORMULAS FOR THE SUPRACHOROIDAL SPACE OF AN EYE AND METHOD |
| DK3515406T3 (da) * | 2016-09-23 | 2024-10-14 | Incept Llc | Intrakamerale depoter til lægemiddeladministration |
| US11160870B2 (en) | 2017-05-10 | 2021-11-02 | Graybug Vision, Inc. | Extended release microparticles and suspensions thereof for medical therapy |
| US11872328B2 (en) * | 2017-08-30 | 2024-01-16 | Hadasit Medical Research Services And Development Ltd. | Devices, kits and methods for reducing and/or preventing intra-abdominal adhesions |
| EP3708605A4 (en) * | 2017-11-06 | 2020-12-16 | Konica Minolta, Inc. | HYDROGEL PARTICLE AND ITS PRODUCTION PROCESS, CELL OR CELLULAR STRUCTURE EACH CONTAINING A HYDROGEL PARTICLE, PROCESS FOR EVALUATING THE ACTIVITY OF A CELL USING A HYDROGEL PARTICLE, AND USE OF A PARTICLE OF HYDROGEL AS A LONG-RELEASE PREPARATION |
| AU2019225742B2 (en) * | 2018-02-20 | 2025-04-24 | Advanced Aesthetic Technologies, Inc. | High concentration hydrogels and related methods |
| US20210315587A1 (en) | 2018-07-02 | 2021-10-14 | Tulavi Therapeutics, Inc. | Methods and devices for in situ formed nerve cap with rapid release |
| CN117598837A (zh) | 2018-07-02 | 2024-02-27 | 图拉维治疗股份有限公司 | 原位形成神经帽的方法和装置 |
| WO2020035819A1 (en) * | 2018-08-15 | 2020-02-20 | Microsert Ltd. | Sustained release component and corresponding drug delivery device with biodegradable material for flow path modification |
| WO2020102810A1 (en) | 2018-11-16 | 2020-05-22 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Thermoresponsive gel eye drop for ocular delivery of cysteamine |
| CN110772376A (zh) * | 2019-11-20 | 2020-02-11 | 韩熠 | 一种用于婴幼儿及儿童的医用眼贴及其制备方法 |
| JP7667747B2 (ja) * | 2020-01-14 | 2025-04-23 | 持田製薬株式会社 | アルギン酸塩を使用した対象の処置のための組合せ及び方法 |
| CA3166738A1 (en) | 2020-02-06 | 2021-08-12 | Charles D. Blizzard | Travoprost compositions and methods for treating ocular diseases |
| EP3884929B1 (en) * | 2020-03-25 | 2023-06-14 | Ocular Therapeutix, Inc. | Ocular implant containing a tyrosine kinase inhibitor |
| JP7803480B2 (ja) * | 2020-03-25 | 2026-01-21 | 学校法人福岡大学 | 眼内膜剥離術に用いられる剤 |
| WO2021222117A1 (en) | 2020-04-27 | 2021-11-04 | Ocular Therapeutix, Inc. | Methods of treating allergic conjunctivitis |
| EP4149400B1 (en) * | 2020-05-15 | 2026-04-22 | Georgia Tech Research Corporation | Methods and compositions for reducing intraocular pressure |
| TWI910236B (zh) | 2020-09-24 | 2026-01-01 | 美商視爾普斯眼科公司 | 包含水凝膠及環孢菌素之持續釋放可生物降解淚小管內插入物 |
| EP4216929A1 (en) | 2020-09-24 | 2023-08-02 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent |
| US12343454B2 (en) | 2020-11-12 | 2025-07-01 | Pramand LLC | Hydrogels formed in situ and composition design for intrauterine use |
| EP4273187A4 (en) | 2021-02-05 | 2024-10-09 | Kao Corporation | HYDROGEL STRUCTURE |
| CN113230019A (zh) * | 2021-04-16 | 2021-08-10 | 南京佑羲医药科技有限公司 | 一种用于眼球玻璃体内植入的长效缓释给药装置 |
| US12582767B2 (en) | 2021-12-30 | 2026-03-24 | Taiyo Weber | Compressible, minimally invasive implants and related systems and methods |
| IL314115A (en) * | 2022-02-01 | 2024-09-01 | Ocular Therapeutix Inc | Controlled release implant for biological agents and corresponding treatment methods |
| US12251466B2 (en) | 2022-04-20 | 2025-03-18 | Pramand LLC | Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels |
| CN115671036A (zh) * | 2022-11-15 | 2023-02-03 | 上海交通大学医学院附属第九人民医院 | 用于治疗眼底和眼内疾病的凝胶药物 |
| CN120897764A (zh) | 2023-04-11 | 2025-11-04 | 视尔普斯眼科公司 | 包含阿西替尼多晶型物iv的眼部植入物 |
| CN116687840B (zh) * | 2023-08-03 | 2023-10-20 | 四川省医学科学院·四川省人民医院 | 一种用于治疗眼部病状的凝胶制剂及其制备方法 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3640741A (en) | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
| US3865108A (en) | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
| US4002173A (en) | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
| DE2437629C3 (de) | 1974-08-05 | 1978-09-21 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von unlöslichen in Wasser nur wenig quellbaren Polymerisaten von N-Vinyllactamen |
| US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
| US4207893A (en) | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
| US4741872A (en) | 1986-05-16 | 1988-05-03 | The University Of Kentucky Research Foundation | Preparation of biodegradable microspheres useful as carriers for macromolecules |
| US5160745A (en) | 1986-05-16 | 1992-11-03 | The University Of Kentucky Research Foundation | Biodegradable microspheres as a carrier for macromolecules |
| IL82834A (en) | 1987-06-09 | 1990-11-05 | Yissum Res Dev Co | Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5304595A (en) | 1988-11-21 | 1994-04-19 | Collagen Corporation | Collagen-polymer conjugates |
| IL90193A (en) | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
| US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| ATE203885T1 (de) * | 1994-09-08 | 2001-08-15 | Stryker Technologies Corp | Bandscheibenkern aus hydrogel |
| US6371975B2 (en) | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
| WO1999021512A1 (en) | 1997-10-27 | 1999-05-06 | The Regents Of The University Of California | Methods and pharmaceutical compositions for the closure of retinal breaks |
| US6958212B1 (en) | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| JP2004523624A (ja) | 2001-02-26 | 2004-08-05 | デューク ユニバーシティ | 新規なデンドリティックポリマー、およびその生物医学的使用 |
| US6913765B2 (en) * | 2001-03-21 | 2005-07-05 | Scimed Life Systems, Inc. | Controlling resorption of bioresorbable medical implant material |
| US20040131582A1 (en) | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
| JP5628467B2 (ja) * | 2003-06-26 | 2014-11-19 | シヴィダ・ユーエス・インコーポレイテッドＰｓｉｖｉｄａ Ｕｓ， Ｉｎｃ． | 生体分解性徐放性ドラッグデリバリーシステム |
| US7129210B2 (en) | 2003-07-23 | 2006-10-31 | Covalent Medical, Inc. | Tissue adhesive sealant |
| WO2006031358A2 (en) | 2004-08-13 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
| WO2006031388A2 (en) | 2004-08-20 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dentritic polymers, crosslinked gels, and their uses in orthopedic applications |
| JP2008520783A (ja) * | 2004-11-16 | 2008-06-19 | ユニベルシテ・ド・リエージュ | ヒドロゲルマトリックスおよびマイクロキャリアを含む活性物質供給システム |
| WO2007001926A2 (en) | 2005-06-24 | 2007-01-04 | Hyperbranch Medical Technology, Inc. | Low-swelling hydrogel sealants for wound repair |
| WO2007005249A2 (en) | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
| US9125807B2 (en) * | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
| US8383161B2 (en) | 2009-12-15 | 2013-02-26 | Incept, Llc | Radioopaque covalently crosslinked hydrogel particle implants |
| US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
| US10226417B2 (en) * | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
| AU2012347926B2 (en) * | 2011-12-05 | 2018-03-15 | Incept, Llc | Medical organogel processes and compositions |
| US20150037422A1 (en) * | 2012-02-22 | 2015-02-05 | Trustees Of Tufts College | Compositions and methods for ocular delivery of a therapeutic agent |
| SG10201701773UA (en) * | 2012-09-06 | 2017-04-27 | Univ Nanyang Tech | Hyaluronic Acid-Based Drug Delivery Systems |
-
2015
- 2015-12-10 AU AU2015360469A patent/AU2015360469B2/en active Active
- 2015-12-10 CA CA2969716A patent/CA2969716C/en active Active
- 2015-12-10 WO PCT/US2015/064975 patent/WO2016094646A1/en not_active Ceased
- 2015-12-10 US US14/965,258 patent/US20160166504A1/en not_active Abandoned
- 2015-12-10 EP EP15820375.2A patent/EP3229779B1/en active Active
- 2015-12-10 CN CN202510552462.2A patent/CN120501693A/zh active Pending
- 2015-12-10 EP EP20214440.8A patent/EP3858329A1/en active Pending
- 2015-12-10 CN CN201580075658.1A patent/CN107205922A/zh active Pending
- 2015-12-10 JP JP2017531184A patent/JP7092502B2/ja active Active
- 2015-12-10 KR KR1020177018919A patent/KR20170117384A/ko not_active Ceased
-
2020
- 2020-12-03 JP JP2020201207A patent/JP2021046429A/ja active Pending
-
2025
- 2025-07-02 US US19/258,825 patent/US20260060921A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017537130A5 (https=) | ||
| Sanjanwala et al. | Polysaccharide-based hydrogels for drug delivery and wound management: a review | |
| Bhavsar et al. | Functionalized and graft copolymers of chitosan and its pharmaceutical applications | |
| Chatterjee et al. | Stimuli-responsive hydrogels: An interdisciplinary overview | |
| TWI718576B (zh) | 溶解特性優秀的透明質酸微結構體 | |
| Khanlari et al. | Bioadhesives: a review | |
| JP2009542384A5 (https=) | ||
| C Patel et al. | Recent patents on stimuli responsive hydrogel drug delivery system | |
| JP2017515869A5 (https=) | ||
| Jennings et al. | Chitosan coatings to control release and target tissues for therapeutic delivery | |
| Lawrence et al. | Ionically cross-linked polymer networks for the multiple-month release of small molecules | |
| Thakker et al. | Inter-polymer complex microspheres of chitosan and cellulose acetate phthalate for oral delivery of 5-fluorouracil | |
| Gilmore et al. | Matrices for combined delivery of proteins and synthetic molecules | |
| Manna et al. | Recent update on alginate based promising transdermal drug delivery systems | |
| RU2016130161A (ru) | Покрытия для медицинских изделий | |
| McGuckin et al. | Transdermal delivery of pramipexole using microneedle technology for the potential treatment of Parkinson’s disease | |
| Floyd et al. | Drug encapsulated aerosolized microspheres as a biodegradable, intelligent glioma therapy | |
| TW200902090A (en) | Transdermal administration device for bisoprolol | |
| WO2014077656A1 (ko) | 초기 약물 방출이 감소된 고분자 미립자를 포함하는 주사용 조성물 및 이의 제조방법 | |
| JP5996990B2 (ja) | 薬剤溶出型フィルム製剤及びその製造方法 | |
| Ahmed et al. | An overview of microsponge as a novel tool in drug delivery | |
| CN108463256A (zh) | 生物可降解的植入物 | |
| Singh et al. | Hydrogel as a novel drug delivery system: recent advancements and patents | |
| Panonnummal et al. | Application of chitosan and its derivatives in transdermal drug delivery | |
| Abou El-Ela et al. | Interpenetrating polymer network (IPN) nanoparticles for drug delivery applications |